These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24339913)

  • 21. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.
    Schneidewind A; Brockman MA; Yang R; Adam RI; Li B; Le Gall S; Rinaldo CR; Craggs SL; Allgaier RL; Power KA; Kuntzen T; Tung CS; LaBute MX; Mueller SM; Harrer T; McMichael AJ; Goulder PJ; Aiken C; Brander C; Kelleher AD; Allen TM
    J Virol; 2007 Nov; 81(22):12382-93. PubMed ID: 17804494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.
    Payne RP; Branch S; Kløverpris H; Matthews PC; Koofhethile CK; Strong T; Adland E; Leitman E; Frater J; Ndung'u T; Hunter E; Haubrich R; Mothe B; Edwards A; Riddell L; Chen F; Harrigan PR; Brumme ZL; Mallal S; John M; Jooste JP; Shapiro R; Deeks SG; Walker BD; Brander C; Landis C; Carlson JM; Prado JG; Goulder PJ
    J Virol; 2014 May; 88(9):4668-78. PubMed ID: 24501417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.
    Miura T; Brockman MA; Brumme ZL; Brumme CJ; Pereyra F; Trocha A; Block BL; Schneidewind A; Allen TM; Heckerman D; Walker BD
    J Virol; 2009 Jan; 83(1):140-9. PubMed ID: 18971283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.
    Wright JK; Brumme ZL; Carlson JM; Heckerman D; Kadie CM; Brumme CJ; Wang B; Losina E; Miura T; Chonco F; van der Stok M; Mncube Z; Bishop K; Goulder PJ; Walker BD; Brockman MA; Ndung'u T
    J Virol; 2010 Oct; 84(20):10820-31. PubMed ID: 20702636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
    Karlsson AC; Iversen AK; Chapman JM; de Oliviera T; Spotts G; McMichael AJ; Davenport MP; Hecht FM; Nixon DF
    PLoS One; 2007 Feb; 2(2):e225. PubMed ID: 17311088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8
    Zhang Y; Murakoshi H; Chikata T; Akahoshi T; Tran GV; Nguyen TV; Gatanaga H; Nguyen KV; Oka S; Kuse N; Takiguchi M
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.
    Bailey JR; O'Connell K; Yang HC; Han Y; Xu J; Jilek B; Williams TM; Ray SC; Siliciano RF; Blankson JN
    J Virol; 2008 Aug; 82(15):7395-410. PubMed ID: 18495769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
    Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
    PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.
    Crawford H; Lumm W; Leslie A; Schaefer M; Boeras D; Prado JG; Tang J; Farmer P; Ndung'u T; Lakhi S; Gilmour J; Goepfert P; Walker BD; Kaslow R; Mulenga J; Allen S; Goulder PJ; Hunter E
    J Exp Med; 2009 Apr; 206(4):909-21. PubMed ID: 19307327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.
    Chopera DR; Woodman Z; Mlisana K; Mlotshwa M; Martin DP; Seoighe C; Treurnicht F; de Rosa DA; Hide W; Karim SA; Gray CM; Williamson C;
    PLoS Pathog; 2008 Mar; 4(3):e1000033. PubMed ID: 18369479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-Cw*03-restricted CD8+ T-cell responses targeting the HIV-1 gag major homology region drive virus immune escape and fitness constraints compensated for by intracodon variation.
    Honeyborne I; Codoñer FM; Leslie A; Tudor-Williams G; Luzzi G; Ndung'u T; Walker BD; Goulder PJ; Prado JG
    J Virol; 2010 Nov; 84(21):11279-88. PubMed ID: 20739527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.
    Serwanga J; Nakiboneka R; Mugaba S; Magambo B; Ndembi N; Gotch F; Kaleebu P
    Vaccine; 2015 Mar; 33(14):1664-72. PubMed ID: 25728323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.